A Multicenter, Randomized, Double Blind, Restasis-Controlled Non-inferiority, Moisview Eye Drops-controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome

Trial Profile

A Multicenter, Randomized, Double Blind, Restasis-Controlled Non-inferiority, Moisview Eye Drops-controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2018

At a glance

  • Drugs Ciclosporin/trehalose (Primary) ; Ciclosporin; Trehalose
  • Indications Dry eyes
  • Focus Registrational; Therapeutic Use
  • Sponsors Huons
  • Most Recent Events

    • 14 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top